PDB18 COST OFFSETS ASSOCIATED WITH USE OF EXENATIDE COMPARED TO GLARGINE FOR THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES
Autor: | Pawaskar, MD, Anderson, J, Zagar, AJ |
---|---|
Zdroj: | In Value in Health 2009 12(7):A404-A404 |
Databáze: | ScienceDirect |
Externí odkaz: |